{"gene":"GPR19","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2016,"finding":"GPR19 knockdown in medial basal hypothalamus of male rats abolished the inhibitory effect of adropin on water deprivation-induced thirst, identifying GPR19 as a candidate receptor mediating adropin's central action on drinking behavior.","method":"siRNA/antisense-mediated reduction of GPR19 mRNA in rat hypothalamus followed by behavioral testing of water drinking","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function with defined behavioral phenotype in a single study; no in vitro binding or signaling confirmation","pmids":["26739651"],"is_preprint":false},{"year":2017,"finding":"Adropin is an endogenous ligand for GPR19; adropin-mediated activation of GPR19 activates the MAPK/ERK1/2 pathway, which drives upregulation of E-cadherin and promotes mesenchymal-to-epithelial transition (MET) in breast cancer cells.","method":"GPR19 overexpression, adropin peptide stimulation, ERK1/2 phosphorylation assay, E-cadherin expression measurement, functional invasion/migration assays in breast cancer cell lines","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor overexpression combined with ligand stimulation and downstream pathway readout (ERK1/2), single lab with multiple orthogonal methods","pmids":["28476646"],"is_preprint":false},{"year":2021,"finding":"GPR19 is expressed in the dorsal suprachiasmatic nucleus (SCN) with circadian oscillation driven by a conserved cAMP-responsive element in its promoter; Gpr19-knockout mice exhibit prolonged circadian period, delayed locomotor activity onset, downregulation of night-peaking clock genes (Bmal1, Gpr176), and reduced light-induced phase-delay capacity accompanied by reduced c-Fos induction in the dorsal SCN.","method":"Gpr19-/- knockout mouse model, circadian locomotor activity monitoring, promoter-CRE reporter assay, c-Fos immunostaining, gene expression analysis in SCN","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple orthogonal phenotypic readouts (circadian period, phase-shifting, molecular clock genes, c-Fos) in a single rigorous study","pmids":["34789778"],"is_preprint":false},{"year":2023,"finding":"Loss of GPR19 in mice increases energy expenditure and decreases activity in both sexes, but causes glucose intolerance and diet-induced hepatomegaly with decreased hepatic fatty acid oxidation gene expression only in males, indicating a sex-dependent role in whole-body metabolic regulation.","method":"GPR19 knockout mouse model, metabolic cage measurements, glucose tolerance tests, hepatic gene expression analysis under high-fat diet","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO model with defined metabolic phenotype and gene expression readout, single lab","pmids":["37061564"],"is_preprint":false},{"year":2023,"finding":"In HEK293 cells, GPR19 expression level determines the signaling paradigm engaged: low expression links to stress and metabolic stress responses; intermediate expression co-regulates DNA damage sensing and repair; high expression associates with cellular senescence pathways.","method":"Proteomic, molecular biological, and bioinformatic analysis of HEK293 cells with titrated GPR19 expression levels","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, proteomics/informatics with limited direct functional validation described in the abstract","pmids":["37239845"],"is_preprint":false}],"current_model":"GPR19 is an orphan class A GPCR that functions as a receptor for the peptide adropin, coupling to the MAPK/ERK1/2 pathway to regulate E-cadherin expression and epithelial phenotype in cancer cells; in the brain it is enriched in the dorsal suprachiasmatic nucleus where it modulates circadian period and light-induced phase resetting, and in the hypothalamus it mediates adropin's inhibition of water drinking; systemic loss of GPR19 produces sex-dependent metabolic dysfunction with impaired fatty acid oxidation and hepatomegaly in male mice."},"narrative":{"mechanistic_narrative":"GPR19 is a class A orphan-derived G protein-coupled receptor that links the secreted peptide adropin to MAPK/ERK1/2 signaling and to the regulation of organismal physiology spanning circadian timing, ingestive behavior, and whole-body metabolism [PMID:28476646, PMID:34789778]. Adropin activation of GPR19 stimulates ERK1/2 phosphorylation and upregulates E-cadherin, driving a mesenchymal-to-epithelial transition and reducing invasion in breast cancer cells [PMID:28476646]; in the rat hypothalamus GPR19 is required for adropin's suppression of water-deprivation-induced drinking [PMID:26739651]. In the brain, GPR19 is enriched in the dorsal suprachiasmatic nucleus where its expression oscillates under control of a cAMP-responsive element, and its loss lengthens circadian period, blunts light-induced phase delays and c-Fos induction, and downregulates night-peaking clock genes including Bmal1 and Gpr176 [PMID:34789778]. Systemic Gpr19 deletion raises energy expenditure in both sexes but produces male-specific glucose intolerance and diet-induced hepatomegaly with reduced hepatic fatty acid oxidation gene expression, defining a sex-dependent metabolic role [PMID:37061564].","teleology":[{"year":2016,"claim":"Identified GPR19 as the candidate central receptor through which adropin acts, addressing how this peptide exerts effects on ingestive behavior.","evidence":"siRNA/antisense knockdown of GPR19 in rat medial basal hypothalamus with water-drinking behavioral assay","pmids":["26739651"],"confidence":"Medium","gaps":["No direct adropin-GPR19 binding or in vitro signaling demonstrated in this study","Mechanism downstream of receptor in hypothalamic neurons not defined"]},{"year":2017,"claim":"Established adropin as an endogenous ligand for GPR19 and connected the receptor to ERK1/2 signaling and an epithelial gene program, defining its molecular signaling axis.","evidence":"GPR19 overexpression plus adropin stimulation with ERK1/2 phosphorylation, E-cadherin expression, and invasion/migration assays in breast cancer cells","pmids":["28476646"],"confidence":"Medium","gaps":["G protein coupling specificity not resolved","Direct receptor-ligand affinity not quantified","Single-lab overexpression context"]},{"year":2021,"claim":"Demonstrated a circadian function for GPR19 in the dorsal SCN, showing it shapes clock period and light-induced phase resetting rather than acting only peripherally.","evidence":"Gpr19-knockout mice with locomotor activity monitoring, promoter-CRE reporter assay, c-Fos immunostaining, and SCN clock-gene expression analysis","pmids":["34789778"],"confidence":"High","gaps":["Whether adropin is the relevant ligand in the SCN was not tested","Signaling pathway linking GPR19 to clock-gene regulation not defined"]},{"year":2023,"claim":"Revealed a sex-dependent role for GPR19 in systemic metabolism, addressing whether the receptor influences whole-body energy and glucose handling.","evidence":"Gpr19 knockout mice with metabolic cage measurements, glucose tolerance tests, and hepatic gene expression under high-fat diet","pmids":["37061564"],"confidence":"Medium","gaps":["Mechanistic basis of male-specific hepatic phenotype unresolved","Tissue-specific contributions not separated by conditional deletion"]},{"year":2023,"claim":"Proposed that GPR19 expression level dictates which stress, DNA-damage, or senescence signaling paradigm is engaged, exploring dose-dependent receptor outputs.","evidence":"Proteomic, molecular, and bioinformatic analysis of HEK293 cells with titrated GPR19 expression","pmids":["37239845"],"confidence":"Low","gaps":["Limited direct functional validation beyond proteomic/informatic correlation","No ligand-dependent confirmation of the proposed paradigms","Single cell line and single lab"]},{"year":null,"claim":"The G protein coupling, structural basis of adropin recognition, and how a single receptor integrates circadian, metabolic, and behavioral outputs across tissues remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined G protein/transducer coupling","No structural model of the adropin-GPR19 interaction","Tissue-specific signaling mechanisms not mechanistically linked"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[2]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3]}],"complexes":[],"partners":["ADROPIN (ENHO)"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15760","full_name":"Probable G-protein coupled receptor 19","aliases":["GPR-NGA"],"length_aa":415,"mass_kda":47.7,"function":"G-protein coupled receptor that plays a role in the regulation of circadian rhythms and energy metabolism. Participates in maintaining proper circadian gene expression in the suprachiasmatic nucleus (SCN), the locus of the master circadian clock in the brain (By similarity). May function as a coordinator of aging-associated metabolic dysfunction, stress response, DNA integrity management, and eventual senescence (PubMed:37239845). Upon binding to adropin, modulates mitochondrial energy metabolism via the p44/42-PDK4 signaling pathway, influencing pyruvate dehydrogenase activity (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q15760/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPR19","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GPR19","total_profiled":1310},"omim":[{"mim_id":"602927","title":"G PROTEIN-COUPLED RECEPTOR 19; GPR19","url":"https://www.omim.org/entry/602927"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":7.8},{"tissue":"pituitary gland","ntpm":7.4},{"tissue":"testis","ntpm":3.7}],"url":"https://www.proteinatlas.org/search/GPR19"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q15760","domains":[{"cath_id":"1.20.1070.10","chopping":"63-257_270-349","consensus_level":"high","plddt":88.6855,"start":63,"end":349}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15760","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15760-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15760-F1-predicted_aligned_error_v6.png","plddt_mean":74.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPR19","jax_strain_url":"https://www.jax.org/strain/search?query=GPR19"},"sequence":{"accession":"Q15760","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15760.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15760/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15760"}},"corpus_meta":[{"pmid":"26739651","id":"PMC_26739651","title":"Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.","date":"2016","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26739651","citation_count":86,"is_preprint":false},{"pmid":"28476646","id":"PMC_28476646","title":"G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28476646","citation_count":76,"is_preprint":false},{"pmid":"31622017","id":"PMC_31622017","title":"Inhibition of the LncRNA Gpr19 attenuates ischemia-reperfusion injury after acute myocardial infarction by inhibiting apoptosis and oxidative stress via the miR-324-5p/Mtfr1 axis.","date":"2019","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/31622017","citation_count":48,"is_preprint":false},{"pmid":"15452705","id":"PMC_15452705","title":"The orphan G-protein-coupled receptor GPR19 is expressed predominantly in neuronal cells during mouse embryogenesis.","date":"2004","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15452705","citation_count":19,"is_preprint":false},{"pmid":"34789778","id":"PMC_34789778","title":"Gpr19 is a circadian clock-controlled orphan GPCR with a role in modulating free-running period and light resetting capacity of the circadian clock.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34789778","citation_count":11,"is_preprint":false},{"pmid":"37061564","id":"PMC_37061564","title":"G-protein coupled receptor 19 (GPR19) knockout mice display sex-dependent metabolic dysfunction.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37061564","citation_count":5,"is_preprint":false},{"pmid":"36362387","id":"PMC_36362387","title":"Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36362387","citation_count":5,"is_preprint":false},{"pmid":"10480372","id":"PMC_10480372","title":"Physical mapping of the G-protein coupled receptor 19 (GPR19) in the chromosome 12p12.3 region frequently rearranged in cancer cells.","date":"1999","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10480372","citation_count":5,"is_preprint":false},{"pmid":"37923782","id":"PMC_37923782","title":"Expression of G protein-coupled receptor GPR19 in normal and neoplastic human tissues.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37923782","citation_count":2,"is_preprint":false},{"pmid":"37239845","id":"PMC_37239845","title":"GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37239845","citation_count":1,"is_preprint":false},{"pmid":"41733804","id":"PMC_41733804","title":"Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancer.","date":"2026","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41733804","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6755,"output_tokens":1279,"usd":0.019725,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7987,"output_tokens":2082,"usd":0.045992,"stage2_stop_reason":"end_turn"},"total_usd":0.065717,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"GPR19 knockdown in medial basal hypothalamus of male rats abolished the inhibitory effect of adropin on water deprivation-induced thirst, identifying GPR19 as a candidate receptor mediating adropin's central action on drinking behavior.\",\n      \"method\": \"siRNA/antisense-mediated reduction of GPR19 mRNA in rat hypothalamus followed by behavioral testing of water drinking\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function with defined behavioral phenotype in a single study; no in vitro binding or signaling confirmation\",\n      \"pmids\": [\"26739651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Adropin is an endogenous ligand for GPR19; adropin-mediated activation of GPR19 activates the MAPK/ERK1/2 pathway, which drives upregulation of E-cadherin and promotes mesenchymal-to-epithelial transition (MET) in breast cancer cells.\",\n      \"method\": \"GPR19 overexpression, adropin peptide stimulation, ERK1/2 phosphorylation assay, E-cadherin expression measurement, functional invasion/migration assays in breast cancer cell lines\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor overexpression combined with ligand stimulation and downstream pathway readout (ERK1/2), single lab with multiple orthogonal methods\",\n      \"pmids\": [\"28476646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR19 is expressed in the dorsal suprachiasmatic nucleus (SCN) with circadian oscillation driven by a conserved cAMP-responsive element in its promoter; Gpr19-knockout mice exhibit prolonged circadian period, delayed locomotor activity onset, downregulation of night-peaking clock genes (Bmal1, Gpr176), and reduced light-induced phase-delay capacity accompanied by reduced c-Fos induction in the dorsal SCN.\",\n      \"method\": \"Gpr19-/- knockout mouse model, circadian locomotor activity monitoring, promoter-CRE reporter assay, c-Fos immunostaining, gene expression analysis in SCN\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple orthogonal phenotypic readouts (circadian period, phase-shifting, molecular clock genes, c-Fos) in a single rigorous study\",\n      \"pmids\": [\"34789778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of GPR19 in mice increases energy expenditure and decreases activity in both sexes, but causes glucose intolerance and diet-induced hepatomegaly with decreased hepatic fatty acid oxidation gene expression only in males, indicating a sex-dependent role in whole-body metabolic regulation.\",\n      \"method\": \"GPR19 knockout mouse model, metabolic cage measurements, glucose tolerance tests, hepatic gene expression analysis under high-fat diet\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO model with defined metabolic phenotype and gene expression readout, single lab\",\n      \"pmids\": [\"37061564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In HEK293 cells, GPR19 expression level determines the signaling paradigm engaged: low expression links to stress and metabolic stress responses; intermediate expression co-regulates DNA damage sensing and repair; high expression associates with cellular senescence pathways.\",\n      \"method\": \"Proteomic, molecular biological, and bioinformatic analysis of HEK293 cells with titrated GPR19 expression levels\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, proteomics/informatics with limited direct functional validation described in the abstract\",\n      \"pmids\": [\"37239845\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPR19 is an orphan class A GPCR that functions as a receptor for the peptide adropin, coupling to the MAPK/ERK1/2 pathway to regulate E-cadherin expression and epithelial phenotype in cancer cells; in the brain it is enriched in the dorsal suprachiasmatic nucleus where it modulates circadian period and light-induced phase resetting, and in the hypothalamus it mediates adropin's inhibition of water drinking; systemic loss of GPR19 produces sex-dependent metabolic dysfunction with impaired fatty acid oxidation and hepatomegaly in male mice.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GPR19 is a class A orphan-derived G protein-coupled receptor that links the secreted peptide adropin to MAPK/ERK1/2 signaling and to the regulation of organismal physiology spanning circadian timing, ingestive behavior, and whole-body metabolism [#1, #2]. Adropin activation of GPR19 stimulates ERK1/2 phosphorylation and upregulates E-cadherin, driving a mesenchymal-to-epithelial transition and reducing invasion in breast cancer cells [#1]; in the rat hypothalamus GPR19 is required for adropin's suppression of water-deprivation-induced drinking [#0]. In the brain, GPR19 is enriched in the dorsal suprachiasmatic nucleus where its expression oscillates under control of a cAMP-responsive element, and its loss lengthens circadian period, blunts light-induced phase delays and c-Fos induction, and downregulates night-peaking clock genes including Bmal1 and Gpr176 [#2]. Systemic Gpr19 deletion raises energy expenditure in both sexes but produces male-specific glucose intolerance and diet-induced hepatomegaly with reduced hepatic fatty acid oxidation gene expression, defining a sex-dependent metabolic role [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified GPR19 as the candidate central receptor through which adropin acts, addressing how this peptide exerts effects on ingestive behavior.\",\n      \"evidence\": \"siRNA/antisense knockdown of GPR19 in rat medial basal hypothalamus with water-drinking behavioral assay\",\n      \"pmids\": [\"26739651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct adropin-GPR19 binding or in vitro signaling demonstrated in this study\",\n        \"Mechanism downstream of receptor in hypothalamic neurons not defined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established adropin as an endogenous ligand for GPR19 and connected the receptor to ERK1/2 signaling and an epithelial gene program, defining its molecular signaling axis.\",\n      \"evidence\": \"GPR19 overexpression plus adropin stimulation with ERK1/2 phosphorylation, E-cadherin expression, and invasion/migration assays in breast cancer cells\",\n      \"pmids\": [\"28476646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"G protein coupling specificity not resolved\",\n        \"Direct receptor-ligand affinity not quantified\",\n        \"Single-lab overexpression context\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated a circadian function for GPR19 in the dorsal SCN, showing it shapes clock period and light-induced phase resetting rather than acting only peripherally.\",\n      \"evidence\": \"Gpr19-knockout mice with locomotor activity monitoring, promoter-CRE reporter assay, c-Fos immunostaining, and SCN clock-gene expression analysis\",\n      \"pmids\": [\"34789778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether adropin is the relevant ligand in the SCN was not tested\",\n        \"Signaling pathway linking GPR19 to clock-gene regulation not defined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed a sex-dependent role for GPR19 in systemic metabolism, addressing whether the receptor influences whole-body energy and glucose handling.\",\n      \"evidence\": \"Gpr19 knockout mice with metabolic cage measurements, glucose tolerance tests, and hepatic gene expression under high-fat diet\",\n      \"pmids\": [\"37061564\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic basis of male-specific hepatic phenotype unresolved\",\n        \"Tissue-specific contributions not separated by conditional deletion\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proposed that GPR19 expression level dictates which stress, DNA-damage, or senescence signaling paradigm is engaged, exploring dose-dependent receptor outputs.\",\n      \"evidence\": \"Proteomic, molecular, and bioinformatic analysis of HEK293 cells with titrated GPR19 expression\",\n      \"pmids\": [\"37239845\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Limited direct functional validation beyond proteomic/informatic correlation\",\n        \"No ligand-dependent confirmation of the proposed paradigms\",\n        \"Single cell line and single lab\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The G protein coupling, structural basis of adropin recognition, and how a single receptor integrates circadian, metabolic, and behavioral outputs across tissues remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No defined G protein/transducer coupling\",\n        \"No structural model of the adropin-GPR19 interaction\",\n        \"Tissue-specific signaling mechanisms not mechanistically linked\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"adropin (ENHO)\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}